BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:38 PM
 | 
Oct 05, 2012
 |  BC Extra  |  Company News

Sialix in deal with Momenta

Sialix Inc. (Newton, Mass.) granted Momenta Pharmaceuticals Inc. (NASDAQ:MNTA) an option to license a preclinical mAb program against cancer-specific glycans containing...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >